Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs4304110 | chr5:1798312 | A/G | 3.26E-6 | 134 | 42.27 | 48.4 | 18.4 | KM Plot |
| TGCT | rs432072 | chr17:39339464 | G/C | 7.11E-7 | 133 | 13.17 | 46.03 | 42.1 | KM Plot |
| TGCT | rs4346064 | chr12:107081599 | C/A | 5.59E-5 | 133 | 44.52 | 45.1 | 28.67 | KM Plot |
| TGCT | rs4380439 | chr3:172439294 | G/A | 8.37E-5 | 134 | 25.33 | 37.42 | 45.83 | KM Plot |
| TGCT | rs4385986 | chr12:107133775 | C/T | 0.000113 | 133 | 42.27 | 45.1 | 28.8 | KM Plot |
| TGCT | rs4433659 | chr12:107082496 | G/T | 5.59E-5 | 133 | 44.52 | 45.1 | 28.67 | KM Plot |
| TGCT | rs4442955 | chr2:109319675 | G/A | 0.000116 | 130 | 25.77 | 60.73 | 37.95 | KM Plot |
| TGCT | rs4454232 | chr7:127775728 | G/A | 8.19E-6 | 134 | 42.27 | 42.15 | 17.1 | KM Plot |
| TGCT | rs4472340 | chr6:42580755 | C/T | 3.23E-8 | 132 | 37.7 | 50.8 | 20.6 | KM Plot |
| TGCT | rs447375 | chr17:39338970 | G/A | 7.11E-7 | 133 | 13.17 | 46.03 | 42.1 | KM Plot |
| TGCT | rs448700 | chr17:39339386 | T/A | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs449817 | chr17:39341266 | A/G | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs4499930 | chr6:42527706 | T/C | 1.86E-10 | 131 | 18.07 | 49.93 | 38.2 | KM Plot |
| TGCT | rs451222 | chr17:39341648 | A/G | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs4514874 | chr2:86182648 | A/G | 1.19E-6 | 134 | 17.28 | 42.27 | 45.1 | KM Plot |